Is the Next Cisplatin Already in Our Laboratory?

References

• Fricker, S. P.;. Medical Uses of Gold Compounds: Past, Present and Future. Gold Bull. 1996, 29(2), 53–60. DOI: 10.1007/bf03215464.
   Google Scholar
• Mjos, K. D.; Orvig, C. Metallodrugs in Medicinal Inorganic Chemistry. Chem. Rev. 2014, 114(8), 4540–4563. DOI: 10.1021/cr400460s.
   PubMed Web of Science ®Google Scholar
• O’Shea, J. G.;. “Two Minutes with Venus, Two Years with Mercury” - Mercury as an Antisyphilitic Chemotherapeutic Agent. J. R. Soc. Med. 1990, 83(6), 392–395. DOI: 10.1177/014107689008300619/ASSET/014107689008300619.FP.PNG_V03.
   PubMed Web of Science ®Google Scholar
• Geier, D. A.; Sykes, L. K.; Geier, M. R. A Review of Thimerosal (Merthiolate) and Its Ethylmercury Breakdown Product: Specific Historical Considerations regarding Safety and Effectiveness. J. Toxicol. Environ. Heal. Part B. 2007, 10(8), 575–596. DOI: 10.1080/10937400701389875.
   PubMed Web of Science ®Google Scholar
• Geier, D. A.; King, P. G.; Hooker, B. S.; Dórea, J. G.; Kern, J. K.; Sykes, L. K.; Geier, M. R. Thimerosal: Clinical, Epidemiologic and Biochemical Studies. Clin. Chim. Acta. 2015, 444, 212–220. DOI: 10.1016/J.CCA.2015.02.030.
   PubMed Web of Science ®Google Scholar
• Dasari, S.; Bernard Tchounwou, P. Cisplatin in Cancer Therapy: Molecular Mechanisms of Action. Eur. J. Pharmacol. 2014, 740, 364–378. DOI: 10.1016/J.EJPHAR.2014.07.025.
   PubMed Web of Science ®Google Scholar
• Hu, Z.; Yu, J.; Gui, G.; Chen, Y.; Huang, R.; Jiang, L.; Kwong, J. S. W.; Li, Y.; Zhang, L. Cisplatin for Testicular Germ Cell Tumors: A Rapid Review. J. Evid. Based. Med. 2016, 9(3), 144–151. DOI: 10.1111/JEBM.12210.
   PubMedGoogle Scholar
• Einhorn, L. H.;. Curing Metastatic Testicular Cancer. Proc. Natl. Acad. Sci. USA. 2002, 99(7), 4592–4595. DOI: 10.1073/PNAS.072067999.
   PubMed Web of Science ®Google Scholar
• Gibson, D. P., (IV);. Anticancer Agents; are We En Route to the Holy Grail or to a Dead End? J. Inorg. Biochem. 2021, 217, 111353. DOI: 10.1016/J.JINORGBIO.2020.111353.
   PubMed Web of Science ®Google Scholar
• Hanif, M.; Hartinger, C. G. Anticancer Metallodrugs: Where Is the Next Cisplatin? Future Med. Chem. 2018, 10(6), 615–617. DOI: 10.4155/fmc-2017-0317.
   PubMed Web of Science ®Google Scholar
• Anthony, E. J.; Bolitho, E. M.; Bridgewater, H. E.; Carter, O. W. L.; Donnelly, J. M.; Imberti, C.; Lant, E. C.; Lermyte, F.; Needham, R. J.; Palau, M., et al. Metallodrugs are Unique: Opportunities and Challenges of Discovery and Development. Chem. Sci. 2020, 11(48), 12888–12917. DOI: 10.1039/D0SC04082G.
   PubMed Web of Science ®Google Scholar
• Lo-Coco, F.; Avvisati, G.; Vignetti, M.; Thiede, C.; Orlando, S. M.; Iacobelli, S.; Ferrara, F.; Fazi, P.; Cicconi, L.; Di Bona, E., et al. Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia. N. Engl. J. Med. 2013, 369(2), 111–121. DOI: 10.1056/NEJMOA1300874/SUPPL_FILE/NEJMOA1300874_DISCLOSURES.PDF.
   PubMed Web of Science ®Google Scholar
• Tsimberidou, A. M.; Fountzilas, E.; Nikanjam, M.; Kurzrock, R. Review of Precision Cancer Medicine: Evolution of the Treatment Paradigm. Cancer Treat. Rev. 2020, 86, 102019. DOI: 10.1016/J.CTRV.2020.102019.
   PubMed Web of Science ®Google Scholar
• Liu, Z.; Delavan, B.; Roberts, R.; Tong, W. Lessons Learned from Two Decades of Anticancer Drugs. Trends Pharmacol. Sci. 2017, 38(10), 852–872. DOI: 10.1016/j.tips.2017.06.005.
   PubMed Web of Science ®Google Scholar
• eEML - Electronic Essential Medicines List. World Healt Organization (WHO), https://list.essentialmeds.org/.
   Google Scholar
• Egorova, K. S.; Ananikov, V. P. Toxicity of Metal Compounds: Knowledge and Myths. Organometallics. 2017, 36(21), 4071–4090. DOI: 10.1021/acs.organomet.7b00605.
   Web of Science ®Google Scholar
• Hoonjan, M.; Jadhav, V.; Bhatt, P. Arsenic Trioxide: Insights into Its Evolution to an Anticancer Agent. J. Biol. Inorg. Chem. 2018, 23(3), 313–329. DOI: 10.1007/s00775-018-1537-9.
   PubMed Web of Science ®Google Scholar
• Caravan, P.; Ellison, J. J.; McMurry, T. J.; Lauffer, R. B. Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. Chem. Rev. 1999, 99(9), 2293–2352. DOI: 10.1021/cr980440x.
   PubMed Web of Science ®Google Scholar
• Meade, T.;. New Magnetic Resonance Contrast Agents as Biochemical Reporters. Curr. Opin. Neurobiol. 2003, 13(5), 597–602. DOI: 10.1016/j.conb.2003.09.009.
   PubMed Web of Science ®Google Scholar
• Casini, A.; Vessieres, A.; Meier-Menches, S. M. Preface. RSC Met. 2019, 2019-Janua(14), P005–P007. DOI: 10.1039/9781788016452-FP005.
   Google Scholar
• Franco Machado, J.; Morais, T. S. Are Smart Delivery Systems the Solution to Overcome the Lack of Selectivity of Current Metallodrugs in Cancer Therapy? Dalt. Trans. 2022, 51(7), 2593–2609. DOI: 10.1039/D1DT04079K.
   PubMed Web of Science ®Google Scholar
• Superchi, C.; Bouvier, F. B.; Gerardi, C.; Carmona, M.; San Miguel, L.; Sánchez-Gómez, L. M.; Imaz-Iglesia, I.; Garcia, P.; Demotes, J.; Banzi, R., et al. Study Designs for Clinical Trials Applied to Personalised Medicine: A Scoping Review. BMJ Open. 2022, 12(5), e052926. DOI: 10.1136/BMJOPEN-2021-052926.
   PubMed Web of Science ®Google Scholar
• Huang, X.; Jain, P. K.; El-Sayed, I. H.; El-Sayed, M. A. Plasmonic Photothermal Therapy (PPTT) Using Gold Nanoparticles. Lasers Med. Sci. 2008, 23, 217–228. DOI: 10.1007/s10103-007-0470-x.
   PubMed Web of Science ®Google Scholar
• Ali, M. R. K.; Wu, Y.; El-Sayed, M. A. Gold-Nanoparticle-Assisted Plasmonic Photothermal Therapy Advances Toward Clinical Application. J. Phys. Chem. C. 2019, 123(25), 15375–15393. DOI: 10.1021/ACS.JPCC.9B01961/ASSET/IMAGES/LARGE/JP-2019-01961P_0003.JPEG.
   Web of Science ®Google Scholar
• Marpu, S. B.; Kamras, B. L.; Nasiri, N. M.; Elbjeirami, O.; Simmons, D. P.; Hu, Z.; Omary, M. A. Single-Step Photochemical Formation of Near-Infrared-Absorbing Gold Nanomosaic within PNIPAm Microgels: Candidates for Photothermal Drug Delivery. Nanomater 2020, 10(7), 1251. 2020, Vol. 10, Page 1251. DOI: 10.3390/nano10071251.
   Web of Science ®Google Scholar
• Hu, X.; Zhang, Y.; Ding, T.; Liu, J.; Zhao, H. Multifunctional Gold Nanoparticles: A Novel Nanomaterial for Various Medical Applications and Biological Activities. Front. Bioeng. Biotechnol. 2020, 8, 990. DOI: 10.3389/FBIOE.2020.00990/BIBTEX.
   PubMed Web of Science ®Google Scholar
• Tang, S.; Zheng, J. Antibacterial Activity of Silver Nanoparticles: Structural Effects. Adv. Healthc. Mater. 2018, 7(13), 1701503. DOI: 10.1002/ADHM.201701503.
   PubMed Web of Science ®Google Scholar
• Mandal, S.; Marpu, S. B.; Hughes, R.; Omary, M. A.; Shi, S. Q.; Mandal, S.; Marpu, S. B.; Hughes, R.; Omary, M. A.; Shi, S. Q. Green Synthesis of Silver Nanoparticles Using Cannabis Sativa Extracts and Their Anti-Bacterial Activity. Green Sustain. Chem. 2021, 11(1), 38–48. DOI: 10.4236/GSC.2021.111004.
   Google Scholar
• Maduray, K.; Parboosing, R. Metal Nanoparticles: A Promising Treatment for Viral and Arboviral Infections. Biol. Trace Elem. Res. 2021, 199(8), 3159–3176. DOI: 10.1007/S12011-020-02414-2.
   PubMed Web of Science ®Google Scholar
• Purniawan, A.; Lusida, M. I.; Pujiyanto, R. W.; Nastri, A. M.; Permanasari, A. A.; Harsono, A. A. H.; Oktavia, N. H.; Wicaksono, S. T.; Dewantari, J. R.; Prasetya, R. R., et al. Synthesis and Assessment of Copper-Based Nanoparticles as a Surface Coating Agent for Antiviral Properties against SARS-CoV-2. Sci. Rep. 2022, 12, 1. DOI: 10.1038/S41598-022-08766-0.
   PubMed Web of Science ®Google Scholar
• Cirri, D.; Pratesi, A.; Marzo, T.; Messori, L. Metallo Therapeutics for COVID-19. Exploiting Metal-Based Compounds for the Discovery of New Antiviral Drugs. Expert Opin. Drug Discov. 2021, 16(1), 39–46. DOI: 10.1080/17460441.2020.1819236.
   PubMed Web of Science ®Google Scholar
• Marzo, T.; La Mendola, D. Strike a Balance: Between Metals and Non-Metals, Metalloids as a Source of Anti-Infective Agents. Inorganics 2021, 9(6), 46. 2021, Vol. 9, Page 46. DOI: 10.3390/inorganics9060046.
   Web of Science ®Google Scholar
• Taylor, D.;. The Pharmaceutical Industry and the Future of Drug Development. In R. E Hester, R. M Harrison Issues in Environmental Science and Technology, Royal Society of Chemistry, 2016; Vol. 2016, pp. 1–33. Janua. DOI: 10.1039/9781782622345-00001
   Google Scholar
• Brown, D. G.; Wobst, H. J. A Decade of FDA-Approved Drugs (2010-2019): Trends and Future Directions. J. Med. Chem. 2021, 64(5), 2312–2338. DOI: 10.1021/ACS.JMEDCHEM.0C01516/ASSET/IMAGES/LARGE/JM0C01516_0025.JPEG.
   PubMed Web of Science ®Google Scholar
• Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings. Adv. Drug Delivery Rev. 1997, 23(1–3), 3–25. DOI: 10.1016/S0169-409X(96)00423-1.
   Web of Science ®Google Scholar
• Shultz, M. D.;. Two Decades under the Influence of the Rule of Five and the Changing Properties of Approved Oral Drugs. J. Med. Chem. 2019, 62(4), 1701–1714. DOI: 10.1021/ACS.JMEDCHEM.8B00686/SUPPL_FILE/JM8B00686_SI_002.CSV.
   PubMed Web of Science ®Google Scholar
• Angelici, L.; Addis, A.; Agabiti, N.; Kirchmayer, U.; Davoli, M.; Belleudi, V. Determinants of First-Line Biological Treatment in Patients with Rheumatoid Arthritis: Results from an Observational Study. Medicine. 2021, 100(19), e25943. DOI: 10.1097/MD.0000000000025943.
   PubMed Web of Science ®Google Scholar
• Geeson, C.; Wei, L.; Franklin, B. D. High-Risk Medicines Associated with Clinically Relevant Medication-Related Problems in UK Hospitals: A Prospective Observational Study. Br. J. Clin. Pharmacol. 2020, 86(1), 165–169. DOI: 10.1111/BCP.14119.
   PubMed Web of Science ®Google Scholar
• Hayes, D. M.; Cvitkovic, E.; Golbey, R. B.; Scheiner, E.; Helson, L.; Krakoff, I. H. High Dose Cis-Platinum Diammine Dichloride. Amelioration of Renal Toxicity by Mannitol Diuresis. Cancer. 1977, 39(4), 1372–1381. DOI: 10.1002/1097-0142(197704)39:4<1372::AID-CNCR2820390404>3.0.CO;2-J.
   PubMed Web of Science ®Google Scholar
• Cvitkovic, E.; Spaulding, J.; Bethune, V.; Martin, J.; Whitmore, W. F. Improvement of Cis-Dichlorodiammineplatinum (NSC 119875): Therapeutic Index in an Animal Model. Cancer. 1977, 39(4), 1357–1361. DOI: 10.1002/1097-0142(197704)39:4<1357::AID-CNCR2820390402>3.0.CO;2-C.
   PubMed Web of Science ®Google Scholar
• Cohen, S. M.; Lippard, S. J. Cisplatin: From DNA Damage to Cancer Chemotherapy. Prog. Nucleic Acid Res. Mol. Biol. 2001, 67, 93–130. DOI: 10.1016/S0079-6603(01)67026-0.
   PubMed Web of Science ®Google Scholar
• Johnstone, T. C.; Suntharalingam, K.; Lippard, S. J. The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs. Chem. Rev. 2016, 116(5), 3436–3486. DOI: 10.1021/acs.chemrev.5b00597.
   PubMed Web of Science ®Google Scholar
• Massai, L.; Cirri, D.; Marzo, T.; Messori, L. Auranofin and Its Analogs as Prospective Agents for the Treatment of Colorectal Cancer. Cancer Drug Resist. 2022, 5(1), 1–14. DOI: 10.20517/cdr.2021.71.
   PubMedGoogle Scholar
• Ramaekers, B. L. T.; Riemsma, R.; Grimm, S.; Fayter, D.; Deshpande, S.; Armstrong, N.; Witlox, W.; Pouwels, X.; Duffy, S.; Worthy, G., et al. Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics 2018, 37(7), 887–894. DOI: 10.1007/S40273-018-0738-Y.
   Web of Science ®Google Scholar